News | December 05, 2023
AstraZeneca discontinues Phase III trials of Stabilizer-CKD and Dialize-Outcomes
STABILIZE-CKD and DIALIZE-Outcomes trials are part of the CRYSTALIZE evidence programme
STABILIZE-CKD and DIALIZE-Outcomes trials are part of the CRYSTALIZE evidence programme
Carmot Therapeutics’s R&D portfolio of clinical stage incretins has great potential to treat obesity, diabetes and potentially other diseases
Covaris is a global leader in the development and deployment of end-to-end solutions for high-throughput genomic and proteomic analysis
High-quality baobab oil sourced in collaboration with UNCCD and the Great Green Wall Initiative
The CAPSUL solution enables optimal process performance for production of premier quality PCL grades at competitive rates
Multi-ethnic innovation helps all complexions appear clearer and more uniform
The acquisition will add 20,000 litres of installed biologics drug substance manufacturing capacity for Syngene
The new ECO grade is made using renewable feedstock
Global Ayurveda Festival organising in Thiruvananthapuram from 1st to 5th December
The product has been in-licensed from Strides and will be commercialized by Amneal
Subscribe To Our Newsletter & Stay Updated
